The team focused on parts of the virus that stay the same across all known HIV strains, an approach that aims to provide a broad-spectrum therapy capable of fighting different HIV variants.

Immunocore’s big swing for a functional HIV cure has cleared its first hurdle. | Immunocore’s big swing for a functional HIV ...

A clinical trial suggests Lenacapavir, a yearly injection, could revolutionise HIV prevention by offering long-term protection, simplifying adherence, and expanding access to at-risk populations.

HIV/AIDS continues to disproportionately affect Black Americans, despite overall progress in reducing infection rates.

In a clinical pilot with 75 South African patients living with HIV, the Tufts research team's device, called a plasma spot card, more accurately measured the extent of a patient's HIV infection ...